The usual Perforomist dosage for COPD is one treatment with a nebulizer twice per day. Specific dosages may vary depending on factors such as other medications you may be taking. It’s important ...

are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless ...

These indications cover severe refractory eosinophilic asthma, for which the antibody ... the antibody is not yet approved for COPD treatment in any nation. The mepolizumab programme of the ...

FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Expect to initiate both trials in Q2 ...